Cassava PTI-125-10
Back to Drug Development Trials
![]()
Drug Development Trials
About the trial
An open-label, long-term extension study to evaluate the safety and tolerability of simufilam 100mg tablets in participants with mild to moderate Alzheimer’s disease.
